Logo image of RUN

SUNRUN INC (RUN) Stock Fundamental Analysis

NASDAQ:RUN - Nasdaq - US86771W1053 - Common Stock - Currency: USD

7.16  +0.29 (+4.22%)

Premarket: 7.04 -0.12 (-1.68%)

Fundamental Rating

2

Overall RUN gets a fundamental rating of 2 out of 10. We evaluated RUN against 92 industry peers in the Electrical Equipment industry. RUN may be in some trouble as it scores bad on both profitability and health. RUN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RUN was profitable.
In the past year RUN has reported a negative cash flow from operations.
RUN had negative earnings in 4 of the past 5 years.
In the past 5 years RUN always reported negative operating cash flow.
RUN Yearly Net Income VS EBIT VS OCF VS FCFRUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

RUN's Return On Assets of -14.30% is in line compared to the rest of the industry. RUN outperforms 53.26% of its industry peers.
RUN has a Return On Equity of -111.43%. This is in the lower half of the industry: RUN underperforms 64.13% of its industry peers.
Industry RankSector Rank
ROA -14.3%
ROE -111.43%
ROIC N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
RUN Yearly ROA, ROE, ROICRUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

RUN's Gross Margin of 16.12% is in line compared to the rest of the industry. RUN outperforms 45.65% of its industry peers.
RUN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
RUN Yearly Profit, Operating, Gross MarginsRUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

RUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RUN has been increased compared to 1 year ago.
The number of shares outstanding for RUN has been increased compared to 5 years ago.
Compared to 1 year ago, RUN has a worse debt to assets ratio.
RUN Yearly Shares OutstandingRUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RUN Yearly Total Debt VS Total AssetsRUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

RUN has an Altman-Z score of -0.21. This is a bad value and indicates that RUN is not financially healthy and even has some risk of bankruptcy.
RUN has a Altman-Z score (-0.21) which is in line with its industry peers.
A Debt/Equity ratio of 4.99 is on the high side and indicates that RUN has dependencies on debt financing.
With a Debt to Equity ratio value of 4.99, RUN is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.99
Debt/FCF N/A
Altman-Z -0.21
ROIC/WACCN/A
WACC4.54%
RUN Yearly LT Debt VS Equity VS FCFRUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.29 indicates that RUN should not have too much problems paying its short term obligations.
The Current ratio of RUN (1.29) is worse than 71.74% of its industry peers.
A Quick Ratio of 0.99 indicates that RUN may have some problems paying its short term obligations.
RUN's Quick ratio of 0.99 is in line compared to the rest of the industry. RUN outperforms 41.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.99
RUN Yearly Current Assets VS Current LiabilitesRUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 116.10% over the past year.
The Earnings Per Share has been growing by 42.86% on average over the past years. This is a very strong growth
RUN shows a decrease in Revenue. In the last year, the revenue decreased by -9.83%.
The Revenue has been growing by 18.87% on average over the past years. This is quite good.
EPS 1Y (TTM)116.1%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%188.13%
Revenue 1Y (TTM)-9.83%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%0.37%

3.2 Future

RUN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -17.21% yearly.
RUN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.81% yearly.
EPS Next Y-164.94%
EPS Next 2Y-55.89%
EPS Next 3Y-37.82%
EPS Next 5Y-17.21%
Revenue Next Year9.57%
Revenue Next 2Y11.66%
Revenue Next 3Y12.76%
Revenue Next 5Y13.81%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RUN Yearly Revenue VS EstimatesRUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
RUN Yearly EPS VS EstimatesRUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -2 -4 -6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

RUN is valuated cheaply with a Price/Earnings ratio of 6.02.
Based on the Price/Earnings ratio, RUN is valued cheaply inside the industry as 97.83% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of RUN to the average of the S&P500 Index (29.35), we can say RUN is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for RUN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 6.02
Fwd PE N/A
RUN Price Earnings VS Forward Price EarningsRUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RUN indicates a somewhat cheap valuation: RUN is cheaper than 60.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 293.46
RUN Per share dataRUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

A cheap valuation may be justified as RUN's earnings are expected to decrease with -37.82% in the coming years.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y-55.89%
EPS Next 3Y-37.82%

More info and screens

0

5. Dividend

5.1 Amount

RUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNRUN INC

NASDAQ:RUN (3/7/2025, 8:00:02 PM)

Premarket: 7.04 -0.12 (-1.68%)

7.16

+0.29 (+4.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners112.59%
Inst Owner Change2.57%
Ins Owners2.24%
Ins Owner Change-0.35%
Market Cap1.62B
Analysts74
Price Target15.17 (111.87%)
Short Float %23.7%
Short Ratio5.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)244.53%
Min EPS beat(2)-157.51%
Max EPS beat(2)646.57%
EPS beat(4)3
Avg EPS beat(4)192.23%
Min EPS beat(4)-157.51%
Max EPS beat(4)646.57%
EPS beat(8)4
Avg EPS beat(8)-307.64%
EPS beat(12)7
Avg EPS beat(12)-99.53%
EPS beat(16)9
Avg EPS beat(16)-66.08%
Revenue beat(2)0
Avg Revenue beat(2)-5.15%
Min Revenue beat(2)-5.73%
Max Revenue beat(2)-4.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.2%
Min Revenue beat(4)-5.73%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-1.88%
Revenue beat(12)6
Avg Revenue beat(12)3.05%
Revenue beat(16)10
Avg Revenue beat(16)3.58%
PT rev (1m)-12.83%
PT rev (3m)-18.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.44%
EPS NY rev (1m)-7.72%
EPS NY rev (3m)10.74%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-4.29%
Revenue NY rev (1m)-2.83%
Revenue NY rev (3m)-4.99%
Valuation
Industry RankSector Rank
PE 6.02
Fwd PE N/A
P/S 0.79
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.63
EV/EBITDA 293.46
EPS(TTM)1.19
EY16.62%
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-15.33
FCFYN/A
OCF(TTM)-3.39
OCFYN/A
SpS9.01
BVpS11.29
TBVpS11.29
PEG (NY)N/A
PEG (5Y)0.14
Profitability
Industry RankSector Rank
ROA -14.3%
ROE -111.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.12%
FCFM N/A
ROA(3y)-7.08%
ROA(5y)-4.59%
ROE(3y)-46.51%
ROE(5y)-28.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.02%
GM growth 5Y-8.23%
F-Score3
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 4.99
Debt/FCF N/A
Debt/EBITDA 266.24
Cap/Depr 435.03%
Cap/Sales 132.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.99
Altman-Z -0.21
F-Score3
WACC4.54%
ROIC/WACCN/A
Cap/Depr(3y)457.15%
Cap/Depr(5y)441.02%
Cap/Sales(3y)111.53%
Cap/Sales(5y)108.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.1%
EPS 3YN/A
EPS 5Y42.86%
EPS Q2Q%188.13%
EPS Next Y-164.94%
EPS Next 2Y-55.89%
EPS Next 3Y-37.82%
EPS Next 5Y-17.21%
Revenue 1Y (TTM)-9.83%
Revenue growth 3Y8.17%
Revenue growth 5Y18.87%
Sales Q2Q%0.37%
Revenue Next Year9.57%
Revenue Next 2Y11.66%
Revenue Next 3Y12.76%
Revenue Next 5Y13.81%
EBIT growth 1Y30.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year133.11%
EBIT Next 3Y40.79%
EBIT Next 5Y28.7%
FCF growth 1Y-1.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.65%
OCF growth 3YN/A
OCF growth 5YN/A